Alembic Pharmaceuticals receives two observations for Karakhadi Injectable Facility

19 Feb 2026 Evaluate

Alembic Pharmaceuticals has received two observations from United States Food and Drug Administration (USFDA) for its Injectable Facility (F-3) located at Karakhadi. The USFDA has conducted an unannounced cGMP inspection at the said facility from February 9, 2026 to February 18, 2026. None of the observations are related to data integrity.

Alembic Pharmaceuticals (Alembic Pharma) is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities.

Alembic Pharma Share Price

762.90 -4.25 (-0.55%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×